Seroprevalence and sociocultural conditionants of Chagas disease in school-aged children of marginal zones of Asunción
GHDx Entry last modified on: Mar 22, 2024
Scientific literature
Displaying 47951 - 48000 of 59997
Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
GHDx Entry last modified on: Mar 3, 2019
Seroprevalence and trend of Helicobacter pylori infection in Gondar University Hospital among dyspeptic patients, Gondar, North West Ethiopia
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5year study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence and Virus Activity of Rift Valley Fever in Cattle in Eastern Region of Democratic Republic of the Congo
GHDx Entry last modified on: May 30, 2020
Séroprévalence et facteurs de risque de l'hépatite virale A, Tlemcen, Algérie
GHDx Entry last modified on: Mar 3, 2019
Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi
GHDx Entry last modified on: Jul 20, 2021
Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil
GHDx Entry last modified on: Jul 20, 2021
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of Alkhurma and other hemorrhagic fever viruses, Saudi Arabia
GHDx Entry last modified on: May 30, 2020
Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti- chlamydia trachomatis lgG and lgM antibodies Among Pregnant women in Diyala province
GHDx Entry last modified on: Jun 24, 2024
Seroprevalence of anti- HEV among blood Donors in Lagos, Nigeria.- A pilot study
GHDx Entry last modified on: Nov 22, 2024
Seroprevalence of anti-cysticercus antibodies among the children living in the urban environs of Maputo, Mozambique
GHDx Entry last modified on: Apr 1, 2024
Seroprevalence of anti-HCV among HIV-infected persons and general population
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of anti-HCV antibodies among blood donors of north India
GHDx Entry last modified on: Jul 20, 2021
Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon
GHDx Entry last modified on: Mar 3, 2019
Seroprevalence of anti-HCV in an urban child population: a preliminary study from Kuala Lumpur
GHDx Entry last modified on: Jul 20, 2021
Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of anti-Helicobacter pylori and anti-cytotoxin-associated gene A antibodies among healthy individuals in center of Iran
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of anti-HEV IgG in children: very early exposure in young children in a hyperendemic region
GHDx Entry last modified on: Oct 30, 2024
Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010)
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran
GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign
GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
GHDx Entry last modified on: Apr 8, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland
GHDx Entry last modified on: May 12, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Senegal: A National Population-Based Cross-Sectional Survey, between October and November 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-VZV IgG in childbearing age women in Pleven region (Bulgaria)
GHDx Entry last modified on: May 23, 2024
Seroprevalence of antibodies against Chikungunya, Dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar
GHDx Entry last modified on: Jul 20, 2021
Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience
GHDx Entry last modified on: Mar 3, 2019
